NEW YORK, Feb. 8, 2024 /PRNewswire/ — The intrauterine contraceptive devices (IUD) market is estimated to grow by USD 965.49 million from 2023 to 2027 at a CAGR of 3.98% according to Technavio. AbbVie Inc., Bayer AG, DKT International, Durbin PLC, EurimPharm Arzneimittel GmbH, EUROGINE…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.